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Treatment Fidelity in Aphasia Randomised Controlled Trials 
Background: Treatment Fidelity is at the heart of evidence based practice and treatment 
fidelity processes help to determine the ‘active ingredients’ of a treatment. Hinckley and 
Douglas in 2013 reviewed treatment fidelity processes in published aphasia trials and found 
14% of aphasia treatment studies reported treatment fidelity. This led the authors to call for 
journals to make treatment fidelity reporting mandatory. Aims: To review the implementation 
and reporting of treatment fidelity processes in recent aphasia RCTs to update on practices 
since 2012. Methods and Procedures: Aphasia RCTs published between 2012-2017 were 
sourced from online databases speechBITE, MEDLINE and CINAHL provided they were: a) 
an investigation of an impairment based treatment for post stroke aphasia; b) not a review, 
protocol, feasibility or replication study c) not a surgical or pharmacological intervention and d) 
published in English. Articles meeting the criteria were rated using Bellg’s treatment fidelity 
areas with the Template for Intervention Description and Replication (TIDieR) checklist 
elements. Outcomes and Results: This search retrieved 110 articles and 42 met the above 
criteria. Nine (21%) articles explicitly reported on treatment fidelity processes. One article (2%) 
contained every element of the recommended treatment fidelity areas. Thirty-seven (88%) 
articles addressed the study design aspect of treatment fidelity by investigating therapy dosage. 
The least addressed aspect of treatment fidelity was ensuring participants used the skills gained 
in treatment in appropriate life settings, with two (2%) articles including this. Conclusions: The 
current review identified 21% of articles explicitly reporting treatment fidelity processes. This 
paper provides updated review evidence from recent RCTs and echoes recommendations for 
greater incorporation of treatment fidelity in research protocols and resulting publications.  
Keywords: aphasia; fidelity; stroke; rehabilitation; speech language pathology  
Introduction 
Aphasia, or language difficulties after stroke, affects approximately 30% of stroke survivors and has 
been identified as one of the top ten research priorities related to life after stroke by the Lancet 
(Pollock, St George, Fenton, & Firkins, 2012). The most recent systematic review by the Cochrane 
Collaboration acknowledged the overall benefit of aphasia therapy however established that no one 
treatment was more effective than another (Brady, Kelly, Godwin, Enderby, & Campbell, 2016). 
Within the systemtatic review experimental speech language pathology (SLP) treatments were 
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compared to ‘conventional’ SLP with insufficient detail provided in most of the studies on what 
therapy was implemented in this second group. This highlights the importance of investigating 
treatments at a sufficient level for comparison of key components. Thorough therapy fidelity 
reporting will assist in answering questions about why therapy works and what makes one treatment 
different from another. Greater clarity in the reporting of studies, beyond a surface level, may give 
therapists access to a sufficient level of detail to determine which treatment may be most appropriate 
for their client and how to replicate the research treatment within real world clinical contexts. Trials 
with positive treatment outcomes and demonstrated high fidelity may assist therapists translate 
evidence into the clinical setting.  
Treatment Fidelity Concept 
Treatment fidelity is the degree to which the administration of a treatment corresponds to the 
specified protocol for the  implementation of that treatment (Kadervak & Justice, 2010). 
Implementation of treatment fidelity processes enhances the reliability and validity of findings 
related to the impact of an intervention (Bellg et al., 2004; Walker et al., 2017). Studies with high 
levels of fidelity have increased external and internal validity as they may be  more replicable and the 
details provided allow comparisons to be made between treatments (Hildebrand et al., 2012; 
Moncher & Prinz, 1991; Resnick et al., 2005; Schlosser, 2002). For trials with positive outcomes, 
treatment fidelity processes can assist in the translation of evidence into clinical practice. This is 
achieved through outlining the components of the prescribed (and adhered to) treatment protocol and 
identifying the possible active components of the intervention (Walker et al., 2017). Treatment 
fidelity reporting also helps explain non-significant results and assists in building a rationale for 
future research by identifying treatment components and processes that could be altered (Resnick et 
al., 2005). The cost of not investigating treatment fidelity is striking and could mean rejecting an 
effective or effacious treatment or accepting an ineffective program (Borrelli et al., 2005). As per 
Borrelli et al. (2005, p. 858) “If a successful trial is described but adherence to protocol is not 
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monitored, applications of the study intervention in real world settings may be compromised or 
unsuccessful potentially at great cost”. Additionally, some authors suggest that  reporting of study 
treatment effects is meaningless if the treatment was not correctly implemented and/or monitored 
(Cordray & Pion, 2006). Sound incorporation of treatment fidelity processes can increase the 
researcher’s confidence that the intervention outcomes are due to the effect of treatment, by ensuring 
that the treatment is delivered as planned. It may also increase the therapist’s confidence in the 
research findings and the knowledge they are implementing an evidenced based treatment as it was 
intended. 
Treatment Fidelity in Research 
Treatment fidelity processes should be incorporated when designing a study, when measuring what 
exactly happened during the intervention and also when reporting the findings. Although including, 
evaluating and reporting on treatment fidelity processes should be central to an intervention study, 
many studies fail to adequately plan or investigate treatment fidelity or fully report their findings 
(Cherney, Patterson, Raymer, Frymark, & Schooling, 2008; Craig et al., 2008). If a scientific basis 
for clinical practice is built on studies that have not effectively incorporated treatment fidelity 
processes then systematic reviews, meta analyses and clinical practice guidelines can be skewed 
(Wheeler, Baggett, Fox, & Blevins, 2006). As treatment fidelity processes are integral at different 
stages of the research process, this literature review will address treatment fidelity sequentially 
through the planned, measured and reported components of research design. 
Planning Treatment Fidelity 
Treatment fidelity is at the heart of what therapists want to know about a treatment with a 
focus on determining what part of a treatment works. Strengthening of the research evidence 
component of the evidence based practice triad will allow for better integration with clinical evidence 
and patient preference and a clearer decision pathway for therapists (Dollaghan, 2011). This is 
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reflected in observations of an increased interest in understanding how interventions work (Cruice, 
Blom Johansson, Isaksen, & Horton, 2018). Researchers need to thoroughly plan, investigate and 
inform therapists about the active ingredients of their treatments and explain the ‘actual nature of the 
process that transforms received therapy into improved health’ (Keith & Lipsey, 1993, p. 51). This 
process begins at the stage of conceptualising and planning the intervention and the program of 
research. The conceptualisation of a theoretical framework underpinning a treatment allows the key 
components that underlie the intervention to be measured and reported. Adopting a treatment fidelity 
framework at the design stage and then developing a plan for monitoring key components of the 
therapy may inform the theory regarding why the intervention does or does not work as the key 
components are linked to the treatment outcome (Walker et al., 2017). This is important for treatment 
efficacy and will enhance the replication process (Turkstra, Norman, Whyte, Dijkers, & Hart, 2016). 
Complex interventions are “health service interventions that are not drugs or surgical 
procedures but have many potential active ingredients” (Oakley, Strange, Bonell, Allen, & 
Stephenson, 2006) p:413). Behavioural interventions, such as those used in SLP are complex and 
have been described as “black boxes” referring to many potential active ingredients and interacting 
components (Walker et al., 2017). It is therefore important that when designing a treatment study 
researchers give significant consideration to the potential theoretical underpinnings of the treatment 
so that those components can be adequately monitored and evaluated. As such the planning and 
analysis of our treatments is just as complex and detailed as the treatment itself. If researchers fail to 
recognise potential factors of influence at the design stage, the appropriate data may not be collected 
and certainly not reported (Walker et al., 2017). Barriers to such planning and analysis are likely 
related to trial funding, time restrictions and methodological concerns. A well-researched RCT has 
the potential to uncover the content of the ‘black box’ of therapy, in particular accruing data on who 
does and does not respond to what type and what intensity of therapy (Godecke, Hird, Lalor, Rai, & 
Phillips, 2012). Just by virtue of a study being designed as a RCT does not mean that it will address 
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‘how’ and ‘why’ treatment changes communication behaviour and who will benefit from it (Dodd, 
2007). There is the assumption that when a treatment is investigated and reported that treatment 
fidelity has been considered (Kaderavek & Justice, 2010). With the attention, effort and funding that 
RCTs receive, as a profession, we cannot risk them being under specified, under researched and 
under reported (Roulstone, 2015). The complexity of these interventions warrants a multifaceted and 
enriched investigation of the effects (Petticrew, 2011).  
Recommendations for ways in which treatment fidelity processes can be implemented in 
trials have been made, including those developed by the treatment fidelity workgroup of the National 
Institutes of Health Behaviour Change Consortium (Bellg et al., 2004). A number of 
recommendations for addressing treatment fidelity in behaviour change studies are outlined across 
five main areas: study design, training providers, delivery of treatment, receipt of treatment and 
enactment of treatment skills (Bellg et al., 2004). The recommendations provide a comprehensive 
way to conceptualise treatment fidelity and have been used as a reference point for establishing the 
scope of this review. Please refer to Table 1 for an overview of these recommendations and the 
original article for complete descriptions (see Bellg et al., (2004)). 
Measuring Treatment Fidelity 
Measuring treatment fidelity is not a substitute for the evaluation of treatment outcomes, 
rather it strengthens the meaning behind the outcomes, and aids in the interpretation of findings as it 
allows the researcher to show that the treatment was delivered as planned (Cordray & Pion, 2006). 
Analysing a study for implementation failures is complex (Brady et al., 2016). Adherence to a 
protocol is not binary and so it needs to be on a measurable continuum to quantify the degree to 
which the protocol was followed (Moncher & Prinz, 1991). As treatment fidelity is inconsistently 
investigated in health behaviour research (Bellg et al., 2004), there are few validated tools to use to 
monitor or evaluate fidelity processes in behavioural interventions (Borrelli et al., 2005). Direct 
observation of treatment sessions using a priori coding categories is considered the gold standard and 
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most thorough and objective way of measuring treatment fidelity (Kaderavek & Justice, 2010). This 
may come in the form of a fidelity monitor using a validated adherence and competence checklist 
and systematically rating the session. It serves the purpose of monitoring treatment integrity and 
collecting data for treatment differentiation (Hildebrand et al., 2012). Direct observation of the 
independent variable may be more prone to bias than dependent variable observations because the 
treatment variable is predefined and an observer might report what the therapist is supposed to do 
rather than what actually happened (Schlosser, 2002).  
Reporting Treatment Fidelity 
Many published articles lack specific detail of treatment as it is planned and provided and 
therefore implementation and replication is difficult (Hoffmann et al., 2014). Guidelines such as 
Template for Intervention Description and Replication (TIDieR) (Hoffmann et al., 2014) have been 
established to encourage more complete reporting and transparency of treatments and to address the 
“remarkably poor” (p. 1) intervention description quality. The TIDieR statement (Hoffmann et al., 
2014) includes general items related to the therapy such as task selection, therapy location and 
dosage. The specificity with which research is presented, in terms of the level of detail provided for 
the intervention and control conditions, needs to be increased to allow for a sufficient standard for 
replication within research and clinical contexts. A recent example of the application of the TIDieR 
checklist to the description of a treatment is a review of reporting standards in communication 
partner training (Cruice et al., 2018). Within this review it was found that 71% of studies addressed 
half the TIDieR checklist items. The TIDieR items that were least frequently reported in the SLP 
literature have been documented as the materials, tailoring and modifications (Cruice et al., 2018). 
Poor reporting is not unique to SLP literature. An investigation of 200 physiotherapy studies found 
that only 23% reported at least half of the recommended 12 TIDieR items (Yamato et al., 2016). 
Concerning treatment fidelity reporting specifically, the TIDieR statement includes items 11 
and 12 that reflect the planned and actual elements of treatment fidelity respectively. In the 
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investigation of the reporting of communication partner training these items were infrequently 
reported (Cruice et al., 2018). Though critical, the lack of reporting of treatment fidelity processes in 
journal articles may reflect a lack of knowledge or understanding of the importance of the concept. 
Within the broader stroke rehabilitation literature most papers have only considered one aspect of 
fidelity such as dose (Walker et al., 2017). Planned aspects of therapy fidelity such as developing a 
protocol were frequently addressed however reporting what was actually delivered in therapy was 
not frequently included (Cruice et al., 2018). 
Research often measures rehabilitation interventions by hours of therapy but tells us little 
about what is done during the specified time, and therefore there is a call for treatments to be 
described using theory, not surface characteristics (Turkstra et al., 2016). This highlights the 
importance of planning treatment fidelity processes at the early research design stage to enable the 
theoretical underpinnings of an intervention to be monitored and then be reported on explicitly. It is 
also reported that there is a lack of detail surrounding the intervention given in control groups. 
Walker et al. (2017) reported that less than 10% of the stroke rehabilitation intervention literature 
fully described the control group intervention to which their intervention was being compared to 
(Walker et al., 2017). The authors recommended describing routine practice in sufficient detail to 
facilitate an indepth understanding of usual care. They questioned the professional integrity of 
researchers working in the field for the poor control group descriptions and highlighted the 
importance of treatment fidelity processes in behavioural interventions.  
Barriers to Treatment Fidelity 
A lack of reporting of details about a treatment may not only be due to poor reporting 
standards as treatment fidelity may not be adequately addressed and implemented within a trial. For 
example the active components of aphasia treatments have not been universally established therefore, 
reporting the ‘therapy recipe’ accurately is a difficult task. However it is unclear whether 
interventions are not incorporating treatment fidelity processes into their trial design or incorporating 
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the processes but not reporting on them. Reasons for treatment fidelity processes being overlooked in 
trial design include a perceived lack of academic reward and the cost of the additional resources 
required to monitor treatment fidelity (Walker et al., 2017). When publishing, word limits may be 
prohibitive for including extra details such as treatment fidelity procedures, (Hoffmann et al., 2014) 
although some RCTs are publishing separate treatment fidelity specific articles to address this (Behn 
et al., 2018; Godecke et al., 2015; Kladouchou, Papathanasiou, Efstratiadou, Christaki, & Hilari, 
2017). As with the implementation and translation of research, costs for therapy fidelity monitoring 
are likely difficult to capture and estimate (Damschroder et al., 2009).  
Treatment Fidelity in Aphasia 
A seminal paper in this area by Hinckley and Douglas (2013) outlined the findings of an 
investigation into the frequency of treatment fidelity reporting in the aphasia literature over a ten year 
span between 2002-2011. All study designs were included provided it was a self identified treatment 
study administered across multiple sessions. Articles that were reviews, republications of older 
studies and retrospective studies were excluded. The raters used binary ‘yes/no’ coding to indicate 
whether treatment fidelity was explicitly reported in the article and whether the treatment description 
in the study was sufficient for replication. Additional descriptive details were noted where a ‘yes’ 
was recorded. A formal framework of treatment fidelity processes and components was not used. Of 
the 149 studies reviewed, 14% reported on treatment fidelity. No apparent upward trend towards an 
increase in reporting over the ten years was identified. A noted limitation of the study being that it 
only reviewed articles published within three American based journals. As a result of their findings 
the authors called for journals to firm up guidelines of treatment fidelity as a requirement for 
publication.  
The adequacy of SLP RCT intervention descriptions, across all SLP practice areas including 
aphasia, was assessed using the TIDieR statement (Hoffmann et al., 2014) and found higher rates of 
treatment fidelity reporting than Hinckley and Douglas (2013) at 46% (Ludemann, Power, & 
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Hoffmann, 2017). However, the authors concluded that this was likely not due to an increase in 
reporting standards but methodological difference in the studies sampling procedures (Ludemann et 
al., 2017). While this study also used a binary ‘yes/no’ coding, it also used a systematic rating 
approach by utilising the TIDieR checklist (Hoffmann et al., 2014). These processes may have 
increased the likelihood of capturing more sutble aspects of treatment fidelity in comparison to the 
Hinckley and Douglas (2013) review. A strength of the Ludemann et al. (2017) review was that 
authors of the RCTs included in the review were contacted to provide additional information about 
the intervention. This process was included to ascertain whether more information was available but 
not reported in the primary publication. The methodological strengths in the Ludemann et al. (2017) 
study provided a guide in the development of the present study. 
In a similar method of review, Richardson (2016) looked at assessment fidelity within aphasia 
intervention studies. The raters also used a systematic approach by investigating six specific 
components of assessment fidelity. These were the reporting of assessment instruments, assessor 
qualifications, assessor training, assessor reliability and assessor blinding. There was greater 
reporting of assessment fidelity with 57% of the 88 studies reviewed providing information relating 
to assessment fidelity. Examination and reporting of assessment fidelity seems more widely done 
than treatment fidelity.  
Aims 
The primary aim of this review was to provide an insight into the reporting of treatment 
fidelity in the aphasia RCT literature as the reporting of treatment fidelity within aphasia RCTs 
specifically has not yet been investigated. Specifically, the aims were to: a) document the frequency 
with which treatment fidelity processes were reported in aphasia RCT literature, b) describe the 
extent to which treatment fidelity processes were reported in aphasia RCT literature, c) explore the 
extent to which treatment fidelity processes were implemented within RCTs by contacting authors 
for further detail. 
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While all study designs were included in the Hinckley and Douglas (2013) review this review 
elected to include RCTs only. Within therapeutic trials, RCTs are considered ‘best evidence’ in an 
evidence based hierarchy and are guided by strict reporting standards as per statements such as 
TIDieR (Hoffman et al., 2014). These statements outline the inclusion of therapy fidelity processes 
as minimum reporting standards.  
Method 
Design 
This study was a descriptive analysis of the reporting and implementation of treatment fidelity 
processes in aphasia RCTS from 2012-2017. 
Procedure 
Search Strategy  
Articles for the review were primarily sourced from speechBITE (www.speechbite.com.au) 
an online database of treatment studies. The database systematically retrieves SLP relevant articles 
from eight databases; MEDLINE, Embase, CINAHL, PsychINFO, ERIC, AMED, LLBA, the EBM 
reviews and Google Scholar (Smith et al., 2010). To ensure all potential articles were captured 
MEDLINE and CINAHL databases were also searched separately, with duplicates excluded. The 
search term aphasia was used with the parameters set as a RCT published between 2012-2017. A 
flow chart of the search procedure and exclusions is presented in Figure 1. The following inclusion 
and exclusion criteria were used when screening the titles and abstracts: a) an investigation of an 
impairment-based treatment for aphasia that occurred post stroke, b) not a review, protocol, 
feasibility or replication study, c) not a surgical or pharmacological intervention and d) published in 
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English. Within this study an impairment-based treatment is defined as a treatment targeting a 
phonological, semantic or syntactic aphasia deficit and is not social or participation based. 
[Insert Figure 1 near here]. 
Rating of Treatment Fidelity 
Articles that met the above criteria were reviewed and the treatment fidelity processes 
outlined in the article were rated using Bellg et al.’s treatment fidelity areas (2004). Bellg et al.’s 
(2004) areas were chosen as they provide a high level of detail into the various ways treatment 
fidelity can be addressed within a study. The areas were divided into items that need to be considered 
when planning a treatment and items that should be considered when the treatment is implemented. 
This matches with the planned and actual items (items 11 and 12) from the TIDieR checklist to 
reflect this intervention description standard (Hoffmann et al., 2014). The resulting checklist is 
presented in Appendix 1. Please refer to Bellg et al., (2004) for complete definitions of each 
treatment fidelity area and goal. A summary is provided below in Table 1. Each article was 
electronically searched for the words ‘fidelity’ and ‘integrity’ to determine the explicit reporting of 
the broad category of treatment fidelity within the article. Regardless of whether the article had 
explicitly used these terms it was further analysed for the reporting of treatment fidelity processes. 
Binary coding (yes/no) for the reporting of treatment fidelity processes was recorded in a 2013 
Microsoft Excel spreadsheet as per Appendix 1. along with other article details. An article was 
marked as addressing the broader area of treatment fidelity if it was marked ‘yes’ for any of the goals 
within the area. Where a ‘yes’ was recorded the location of the information within the article and the 
details about the reported part of treatment fidelity were noted to allow description. If the article 
referred to the information in a secondary location this was investigated. Authors were contacted to 
identify missing information and to determine whether treatment fidelity measures were 
implemented but not reported. Authors were asked to provide additional information based on the 
coding described above. Coding was separated by identifying whether the information was provided 
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in the primary publication, secondary publication or from author contact. The first and last author of 
this paper reviewed each article independently and then discussed any differences in ratings until 
consensus was reached. 
[Insert Table 1 near here] 
Analysis  
Ratings were summarised for each item with a total yes/no rating. Descriptive statistics were used to 
analyse the data according to our aims. 
Results 
One hundred and eighty articles were identified in the initial search across the three 
databases. Seventy articles were excluded as duplications. One hundred and ten titles and abstracts 
were screened and 68 excluded for the reasons listed in Figure 1. A total of 42 full text articles were 
retrieved for rating. Over the six years from 2012-2017 the average number of treatment studies that 
met the criteria was seven per year. A table with the complete reference list and ratings for each 
article is provided in Appendix 2.  
Of the studies in this review nine (21.3%) explicitly used the words ‘treatment fidelity’ or 
‘integrity’ in their papers. One article provided additional treatment fidelity information in a 
supplement. All authors were contacted and seven (16.7%) authors provided additional information 
that was included in these results. Using the Bellg et al.’s treatment fidelity areas (2004) with the 
TIDieR checklist as a framework (Hoffmann et al., 2014), the number of studies that presented each 
broader aspect of treatment fidelity is outlined in Table 2.  Marshall et al., (2016) was the only article 
(2.4%) to address all five of Bellg et al.’s (2004) treatment fidelity areas after additional information 
was provided via author contact. The most frequently addressed aspect of treatment fidelity was 
study design with information included in 37 (88.1%) articles. This was commonly done in the form 
of information regarding dosage within and across conditions. The least addressed aspect of 
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treatment fidelity was enactment of treatment skills with one (2.4%) study reporting on this. 
Enactment of treatment skills included ensuring the participant’s use of behavioural and cognitive 
skills outside the research therapy setting. Figure 2. Presents the number of articles that addressed the 
subcategories of Bellg et al.’s (2004) treatment fidelity areas. 
[Insert table 2 near here]. 
[Insert Figure 2 near here]. 
Discussion 
Explicit reporting of Treatment Fidelity 
This paper reviewed 42 aphasia RCTs and identified that 21% of articles explicitly reported 
treatment fidelity processes. Methodological differences between this and the Hinckley and Douglas 
(2013) review mean that a direct comparison is not possible and this review provides a guide to 
reporting in RCTs only. The majority of studies included in the current review addressed areas of 
treatment fidelity without using the explicit terms ‘fidelity’ or ‘integrity’. Considering the 
significance of therapy fidelity to the evaluation of interventions it is important that researchers use 
this terminology as a minimum standard in the reporting of all aphasia treatment studies. The push 
for complete intervention description as per TIDieR (Hoffmann et al., 2014) and other reporting 
statements for clinical trials (e.g. CONSORT, SPIRIT) may contribute to an increase in therapy 
fidelity reporting. There is a risk that reporting of treatment fidelity may increase superficially 
through the use of these statements; however, addressing active ingredients and the theory behind the 
therapy in sufficient detail may remain an ongoing goal for aphasia research. 
Treatment Fidelity Processes 
This review used the TIDieR statement (Hoffmann et al., 2014) and treatment fidelity areas 
and goals from Bellg et al., (2004) as a framework for measuring aspects of treatment fidelity and 
differs methodologically from Hinckley and Douglas (2013) in this way. The planned aspects of 
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TIDieR  were more commonly reported than the aspects related to the implementation of the therapy, 
echoing Cruice et al. (2018) findings that reporting what was delivered was not frequently done. 
Even when reporting the planned aspects of therapy fidelity there was under reporting of the 
theoretical rationale for the therapy, or any possible active ingredients, making it difficult to 
determine potential factors that may influence the intervention (Walker et al., 2017). The least 
frequently addressed parts of treatment fidelity were protocol adherence and generalisation beyond 
the therapy room. These factors may be more complex and labour intensive to implement and 
measure within research protocols as they require additional processes to be implemented alongside 
the intervention elements of the research.  
If aspects of therapy implementation are then not investigated or reported, readers can only 
assume that the intervention was implemented as planned. Current fidelity research indicates this is 
not always the case in complex study designs. For example, Bakheit et al., (2007) reported that only 
thirteen of the fifty one participants received the planned intensive aphasia intervention. In an 
investigation of whether patients with chronic stroke who underwent task oriented treadmill training 
could motor learn and improve cardiovascular fitness, Resnick (2011) reported that only 48% of the 
sample reached the study goal of exercising at 60-70% of their maximum heart rate. The majority of 
studies in this review did not  report the therapy, as it was implemented, behind the closed therapy 
door. With complex study designs and multifaceted behavioural interventions the assumption that the 
intervention was delivered as planned is not yet supported in the literature. A reconceptualization of 
and attention to the monitoring and reporting of aphasia interventions is required. In addition to 
monitoring protocol adherence and the delivery of the key component(s) of the therapy, articles 
should specify information such as why that mode of administration was assumed to be effective 
(Turkstra et al., 2016). Monitoring and reporting of treatment fidelity processes will support the 
development of the evidence base needed to understand treatments more deeply and guide 
professional standards, strengthening this part of the evidence based pratice triad (Dollaghan, 2011).   
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Dosage 
Treatment dosage was the most commonly reported planned element of treatment. This was 
most frequently reported in terms of the number of minutes of therapy received. Across many 
disciplines, rehabilitation interventions are frequently measured by minutes or hours of therapy 
provided (Turkstra et al., 2016). Measuring dosage in terms of time either assumes that each therapy 
minute across interventions is equal, or that time is the main ingredient in the intervention. Some 
studies acknowledged that dosage could be measured in terms of the number of times the active 
ingredient occurs in the session rather than time, as “therapy intensity is not sufficiently defined as 
the number of therapy hours multiplied by the total number of sessions” (Woldag, Voigt, Bley, & 
Hummelsheim, 2017, p. 78).  
There is the question of whether it is the dosage, potential active ingredients or both within a 
therapy that results in a therapy effect. Frequently, and with many of the studies in this review, little 
detail was provided on the details of a specific intervention. Only with investigation of protocol 
adherence in each session can dosage be reconceptualised to be more reflective of treatment. 
Research is moving towards studying dosage and tailoring ingredients including schedules of 
practice, handling of errors and other error control to implement approaches that are effective 
(Turkstra et al., 2016).   
Transcranial Magnetic Stimulation (TMS) Studies 
It should be noted that the results of this study may have been impacted by the inclusion of 15 
TMS studies in this review. TMS intervention was often accompanied by traditional speech therapy 
and, within these studies descriptions of the behavioural intervention were particularly poor. For 
example some studies limited their therapy description to phrases such as ‘anomia treatment’ 
containing no other detail.  However the dosage of the more structured TMS element of intervention 
was well described within these studies. This may reflect a greater ease of measurement compared to 
the behavioural therapy aspect and may have inflated the findings of the review. Not only does this 
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mean that treatment fidelity was likely not adequately investigated but replication or generalisation 
from the information included in the paper is unlikely. Studies that present efficacy for TMS 
combined with traditional speech therapy are difficult to implement in practice due to the poor 
therapy fidelity on the behavioural element.  
Limitations 
This review focused on the reporting of treatment fidelity within papers. However, 
supplementary papers were reviewed and authors were contacted to provide additional information to 
address the implementation aim of the review. As such we believe that the review represents an 
adequate guide to the implementation of treatment fidelity within aphasia RCTs. However, it remains 
likely that the reported figures are an underestimation of the treatment fidelity processes that were 
incorporated in each study as they may not have been reported in primary, supplementary or author 
contact. A limitation of this study is that it only included RCTs. Because of the implementation of 
reporting statements in RCTs, these studies may be more likely to report treatment fidelity and so the 
findings may not be generalisable to the broader aphasia literature. 
Future Directions 
The TIDieR (Hoffman et al., 2014) statement and recommendations from the treatment 
fidelity workgroup of the National Institutes of Health Behaviour Change Consortium (Bellg et al., 
2004) represent the current goal standard for addressing treatment fidelity within research. 
Recommendations for monitoring intervention fidelity include videoed therapy sessions and 
subsequent analysis of these videos according to apriori criteria for the key components of the 
therapy. This procedure is complex and expensive, however is vital to understanding therapy theory. 
At the time of publishing, a portion of aphasia trials that are currently underway have published 
research protocols and are video recording therapy sessions. These studies include the Aphasia 
Action Success Knowledge (ASK) trial (Worrall et al., 2016), The Very Early Rehbailitation in 
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SpEech (VERSE) trial (Godecke et al., 2013), SUpporting well-being through PEeR-Befriending 
(SUPERB) trial (Hilari et al., 2019) and the COMPARE trial (Rose et al., 2017). Some trials are 
presenting their treatment fidelity processes at conferences (see Behn et al., (2018) and Godecke et 
al., (2015)). This is reflecting an increased focus in the area and due to these efforts, a future review 
into treatment fidelity reporting would likely report higher figures. As it becomes a priority to 
investigate treatment fidelity we encourage researchers to submit adequate budgets for inclusion in 
grants and funding bodies to recognise and prioritise funding for studies that include comprehensive 
treatment fidelity monitoring.  
Conclusion 
We agree with Ciccone et al. (2016) that “future aphasia studies require substantial attention to 
therapy adherence and differentiation to enable conclusive statements regarding therapy efficacy” 
(pg. 580). This review has highlighted the need for the research community to increase their therapy 
fidelity implementation and reporting standards to achieve a greater understanding of how and why 
our treatments work. The TIDieR (Hoffman et al., 2014) and Bellg et al. (2004) frameworks were 
particularly valuable in evaluating reporting which may guide the development and implementation 
of fidelity processes in future studies. The ultimate aim of our research is to build a body of evidence 
for therapies to add value to the service that speech therapists provide.  
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Table 1. Bellg’s (2004) Treatment Fidelity Recommendations 
 
Area  Goal 
Study Design Ensure same treatment dose within conditions 
 Ensure equivalent dose across conditions 
 Plan for implementation setbacks 
Training providers Standardise training 
 Ensure provider skill acquisition 
 Minimise therapist drift 
 Accommodate provider differences 
Delivery of treatment Control for provider differences 
 Reduce differences within treatment 
 Ensure adherence to protocol 
 Minimise contamination between conditions 
Receipt of treatment Ensure participant comprehension 
 Ensure participant ability to use cognitive skills 
 Ensure participants ability to perform behavioural skills 
Enactment of treatment skills Ensure participant use of cognitive skills 
 Ensure participant use of behavioural skills 
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Table 2. Articles that addressed presented aspects of Treatment Fidelity (TF)  
TIDieR element TF Area (Bellg et al. 2004) Number of articles  
11. Planned Study Design 37 (88.1%) 
 Training providers 20 (47.6%) 
 Delivery of treatment 21 (50%) 
12. Actual Receipt of treatment 5 (11.9%) 
 Enactment of treatment skills 1 (2.40%) 
Note. An article was marked as addressing Bellg et al.’s (2004) broader area of treatment fidelity if it 
was marked ‘yes’ for any of the goals within the area. See Appendix 1 ‘Treatment Fidelity Area 
Checklist’ for areas and corresponding goals. 
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Figure 1. Flow chart indicating the selection of articles 
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Figure 2. The number of articles that addressed Bellg et al.’s (2004) Treatment Fidelity 
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Appendix 1. Treatment Fidelity Area Checklist 
TIDieR 
Element 
Area (Bellg et 
al. 2004) 
Goal Location (article, 
supplement, author) 
Y/N 
Description 
11. Planned Study Design 11.1 Ensure same treatment 
dose within conditions 
  
 11.2 Ensure equivalent dose 
across conditions 
  
  11.3 Plan for implementation 
setbacks 
  
 Training 
providers 
11.4 Standardise training   
  11.5 Ensure provider skill 
acquisition 
  
  11.6 Minimise therapist drift   
  11.7 Accommodate provider 
differences 
  
 Delivery of 
treatment 
11.8 Control for provider 
differences 
  
  11.9 Reduce differences within 
treatment 
  
12. Actual  12.1 Ensure adherence to 
protocol 
  
  12.2 Minimise contamination 
between conditions 
  
 Receipt of 
treatment 
12.3 Ensure participant 
comprehension 
  
  12.4 Ensure participant ability 
to use cognitive skills 
  
  12.5 Ensure participants ability 
to perform behavioural skills 
  
 Enactment of 
treatment skills 
12.6 Ensure participant use of 
cognitive skills 
  
  12.7 Ensure participant use of 
behavioural skills 
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Appendix 2. Summary of Studies Reviewed 
Summary of Studies Reviewed (organised by Year) 
Full Reference List below 
Article  TF Explicitly Reported TF Goals addressed 
2012   
(Barwood et al., 2012)* No 11.1,11.2 
(Bowen, Hesketh, Patchick, Young, Davies, Vail, Long, Watkins, 
Wilkinson, Pearl, Lambon Ralph, et al., 2012) 
No 11.1,11.2,11.4,11.6,11.9,12.1,12.2 
(Bowen, Hesketh, Patchick, Young, Davies, Vail, Long, Watkins, 
Wilkinson, Pearl, Ralph, et al., 2012) 
Yes 11.1,11.2,11.4,11.5,11.6,11.8,11.9,12.1,12.2,12.3 
(Conklyn, Novak, Boissy, Bethoux, & Chemali, 2012) No 12.2 
(Godecke et al., 2012) No 11.1,11.2,11.4,11.5,11.9,12.1 
(Kindler et al., 2012; Medina et al., 2012)* No 11.1,11.2 
(Medina et al., 2012)* No 11.1,11.2 
(Palmer et al., 2012) No 11.1,11.4,11.6,11.9,12.1 
(Raymer et al., 2012) Yes 11.1,11.2,12.1 
(Waldowski, Seniow, Lesniak, Iwanski, & Czlonkowska, 2012)* No Nil 
2013   
(Barwood et al., 2013)* No 11.1,11.2 
(Heiss et al., 2013)* No Nil 
(Kendall, Hunting Pompon, Brookshire, Minkina, & Bislick, 2013) No 11.1,11.2,11.4 
(Martins et al., 2013) No 11.2,.11.4,11.6 
(Polanowska, Lesniak, & Seniow, 2013)* Yes 11.1,11.2,11.8,12.2 
(Seniów et al., 2013)* No 11.1,11.2,12.2 
(Thiel et al., 2013)* No 11.1,11.2 
2014   
(Altmann et al., 2014) No 11.1,11.2,11.8,12.1 
(Cherney, Kaye, & van Vuuren, 2014) Yes 11.1,11.2,11.4,11.5,11.6,11.7,11.8,11.9,12.1,12.3,12.5 
(Khedr et al., 2014)* No 11.1,11.2,11.7,11.8 
(Mattioli et al., 2014)* No 11.1,11.2 
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(Nouwens et al., 2014) No 11.6 
(Sickert, Anders, Münte, & Sailer, 2014) No 11.1,11.2 
(Tsai et al., 2014)* No 11.1,11.2 
(van der Meulen, van de Sandt-Koenderman, Heijenbrok-Kal, Visch-
Brink, & Ribbers, 2014) 
No 11.1,11.2,11.4,11.9 
(Wang et al., 2014)* No Nil 
2015   
(Cherney, Kaye, Lee, & van Vuuren, 2015) Yes 11.1,11.2,11.4,11.5,11.6,11.7,11.8,11.9,12.1,12.4 
(Kendall, Oelke, Brookshire, & Nadeau, 2015) Yes 11.1,11.2,11.4,11.5,11.6,11.7,11.9,12.2 
(Rubi-Fessen et al., 2015)* Yes 11.1,11.2,11.4,11.3(a), 12.2 
(Szaflarski et al., 2015) Yes 11.1,11.2,11.4,11.5(a),11.6(a),11.7(a),11.9 
(Wilssens, Vandenborre, Van Dun, Verhoeven, & Visch-Brink, 2015) No 11.1,11.2,11.4,11.5,11.7,11.9,12.1,12.2 
2016   
(Ciccone et al., 2016) Yes 11.1,11.2,11.3,11.4,11.6,11.8(a),11.9,12.1(a),12.2(a) 
(Kurland, Stanek Iii, Stokes, Minming, & Andrianopoulos, 2016) No 11.1,11.2,12.2,12.3 
(Marshall et al., 2016) No 11.1(a),11.2(a),11.3(a),11.5(a),11.6(a),11.7,11.9(a), 
12.4(a),12.5(a),12.6(a),12.7(a) 
(Meinzer, Darkow, Lindenberg, & Flöel, 2016)* No 11.1,11.2,11.4(a),11.8,11.9,12.1 
(Raglio et al., 2016) No 11.1,11.2 
(Stahl, Mohr, Dreyer, Lucchese, & Pulvermüller, 2016) No 11.1,11.2 
2017   
(Breitenstein et al., 2017) No 11.1,11.2,11.4,11.5,11.6,11.9,12.1,12.2 
(Höeg Dembrower, von Heijne, Laska, & Laurencikas, 2017) No Nil 
(Nouwens et al., 2017) No 11.1,11.2,11.6,11.9(a),12.1 
(Woldag et al., 2017) No 11.1,11.2 
(Zumbansen et al., 2017) No 11.1,11.2 
 
Note. *denotes a Transcranial Magnetic Stimulation study. (a) = changed according to additional information provided by the author. Not 
reported in original article or any available supplement. 
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